Clinical Trial Update: 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 177Lu-DOTATATE in Stage IV or recurrent breast cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 177Lu-DOTATATE (Lutetium-177 dotatate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING